Pearlly Yan
11PUBLICATIONS
71CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Nov 06, 2025
Addition of Ianalumab (VAY736) to Ibrutinib in Patients with Chronic Lymphocytic Leukemia on Ibrutinib Therapy: Results from a Phase Ib Study.Kerry A Rogers, Pearlly Yan, Ian W Flinn
|Jul 08, 2024
Insulin receptor orchestrates kidney antibacterial defenses.Laura Schwartz, Aaron Simoni, Pearlly Yan
|Feb 13, 2023
RAB7 deficiency impairs pulmonary artery endothelial function and promotes pulmonary hypertension.Bryce Piper, Srimathi Bogamuwa, Tanvir Hossain
|Jan 07, 2023
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformation.Zachary A Hing, Janek S Walker, Ethan C Whipp
|Nov 14, 2022
VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia.Steven Sher, Ethan Whipp, Janek Walker
|Sep 16, 2022
Targeting OXPHOS de novo purine synthesis as the nexus of FLT3 inhibitor-mediated synergistic antileukemic actions.Pu Zhang, Lindsey T Brinton, Mehdi Gharghabi
Pageof 2
Frequent Collaborators
4 joint publications
Rosa Lapalombella
4 joint publications
James S Blachly
3 joint publications
Jennifer Woyach
3 joint publications
Steven Sher
3 joint publications
Ralf Bundschuh
3 joint publications
Janek S Walker
3 joint publications
Vincenzo Coppola
3 joint publications
Yi-Wen Huang
2 joint publications
Alexander Pan
2 joint publications
Li-Ling Lin
